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Purpose: This study was designed to identify pathogenic mutations causing autosomal recessive retinitis pigmentosa (RP)
in consanguineous Pakistani families.
Methods: Two consanguineous families affected with autosomal recessive RP were identified from the Punjab Province
of Pakistan. All affected individuals underwent a thorough ophthalmologic examination. Blood samples were collected,
and genomic DNAs were extracted. Exclusion analysis was completed, and two-point LOD scores were calculated.
Bidirectional sequencing of the β subunit of phosphodiesterase 6 (PDE6β) was completed.
Results: During exclusion analyses both families localized to chromosome 4p, harboring PDE6β, a gene previously
associated with autosomal recessive RP. Sequencing of PDE6β identified missense mutations: c.1655G>A (p.R552Q)
and c.1160C>T (p.P387L) in families PKRP161 and PKRP183, respectively. Bioinformatic analyses suggested that both
mutations are deleterious for the native three-dimensional structure of the PDE6β protein.
Conclusions: These results strongly suggest that mutations in PDE6β are responsible for the disease phenotype in the
consanguineous Pakistani families.
Retinitis pigmentosa (RP) is one of the most common
retinal  hereditary  disorders,  affecting  approximately  1  in
5,000  people  worldwide  [1].  It  is  a  progressive  rod–cone
dystrophy  that  manifests  with  nyctalopia,  gradual
degeneration of visual fields, and eventual decline of visual
acuity. Clinical symptoms include pigmentary deposits in the
retina,  waxy  disc  pallor,  and  attenuation  of  retinal  blood
vessels [2]. RP is genetically a heterogeneous disease that is
inherited as an autosomal dominant, autosomal recessive, as
well as an X-linked trait [3]. To date, more than 50 loci and
genes have been implicated in the pathogenicity of autosomal
recessive RP.
Phosphodiesterase 6 (PDE6) is an important component
of the visual cascade. It consists of two catalytic subunits,
namely,  PDE6α  and  PDE6β,  and  a  regulatory  subunit,
PDE6γ [4]. PDE6 mediates the hydrolysis of cyclic guanine
monophosphate (cGMP), and regulation of cGMP levels is
essential  for  the  phototransduction  cascade  as  prolonged
imbalance in cGMP metabolism can potentially disrupt the
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visual signaling pathway [5]. PDE6β encodes the β subunit of
PDE6  and  has  been  implicated  in  the  pathogenesis  of
autosomal dominant RP [6], autosomal recessive RP [7], and
congenital stationary night blindness [8]. According to the
human gene mutation database, 21 mutations in PDE6β have
been  identified  in  patients  with  autosomal  recessive  RP
(arRP).
Here, we report two consanguineous families from the
Punjab province of Pakistan that were diagnosed with arRP.
Clinical  records  available  to  us  are   suggestive  of  an  early, 
most   probably  a   congenital,   onset.   Exclusion   analysis
revealed  linkage  with significant  logarithm of odds (LOD)
scores to chromosome  4pter-p16.2,  a  region  that harbors 
PDE6β.     Sequencing   of    PDE6β    identified    missense  
mutations that were not present in ethnically matched control
chromosomes.
METHODS
Clinical  assessment:  One  hundred  and  twenty-five
consanguineous Pakistani families with nonsyndromic arRP
were recruited to participate in a collaborative study between
the  National  Center  of  Excellence  in  Molecular  Biology,
Lahore, Pakistan, and the National Eye Institute, Bethesda,
Maryland, to identify new disease loci causing inherited visual
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1373diseases.  Approval  of  the  Institutional  review  board  was
obtained  for  this  study  from  both  institutes,  and  the
participating subjects gave informed consent consistent with
the tenets of the Declaration of Helsinki. A detailed pedigree
drawing and medical history was obtained by interviewing
family  members.  Funduscopy  was  performed  at  Layton
Rehmatulla  Benevolent  Trust  Hospital,  Lahore.
Electroretinography  (ERG)  measurements  were  recorded
with equipment manufactured by LKC (Gaithersburg, MD).
Rod responses were determined through an incident flash
attenuated by −25dB and the rod-cone response was measured
at 0dB. Isolated cone responses were recorded at 0dB with a
30Hz flicker over a background illumination of 17–34 cd/
m2. Approximately 10 ml of blood samples were drawn from
affected and unaffected members of the family and stored in
50 ml Sterilin® falcon tubes (BD Biosciences, San Jose, CA)
containing 400 μl of 0.5 M EDTA. Blood samples were kept
at −20 °C for long- term storage.
DNA extraction: DNA was extracted by a nonorganic method
as  described  previously  [9,10].  Briefly,  aliquots  of  10  ml
blood samples were mixed with 35 ml of TE buffer (10 mM
Tris-HCl, 2 mM EDTA, pH 8.0), and the TE–blood mixture
was centrifuged at 1,800× g for 20 min. The supernatant was
discarded, and the pellet was resuspended in 35 ml of TE
buffer and centrifuged at 1,800× g for 20 min. The TE washing
was repeated two to three times, and the washed pellet was
resuspended in 2 ml of TE. A protein digestion cocktail of
6.25 ml (50 μl [10 mg/ml] of proteinase K, 6 ml TNE buffer
[10 mM Tris HCl, 2 mM EDTA, 400 mM NaCl], and 200 μl
of 10% sodium dodecyl sulfate) was added to the resuspended
pellets and incubated overnight in a shaker (250 rpm) at 37 °C.
The digested proteins were precipitated by adding 1 ml of 5
M NaCl, followed by vigorous shaking and chilling on ice for
15  min.  The  precipitated  proteins  were  pelleted  by
centrifugation  at  1,800×  g  for  20  min  and  removed.  The
supernatant  was  mixed  with  an  equal  volume  of  phenol/
chloroform/isoamyl alcohol (25:24:1), and the aqueous layer
containing the genomic DNA was carefully collected. The
DNA  was  precipitated  with  isopropanol  and  pelleted  by
centrifugation at 2,400× g for 15 min. The DNA pellets were
washed with 70% ethanol and dissolved in TE buffer. The
DNA concentration was determined with a SmartSpec plus
Bio-Rad spectrophotometer (Bio-Rad, Hercules, CA).
Exclusion analyses: Exclusion analyses were performed with
highly polymorphic fluorescent short tandem repeat (STR)
markers spanning all known/reported loci for arRP. PCR for
exclusion analyses were performed in a PCR System 9700
(Applied Biosystems). Briefly, each reaction was performed
in a 5-μl mixture containing 40 ng genomic DNA, various
combinations  of  10  μM-dye-labeled  primer  pairs,  1×
TABLE 1. PRIMER SEQUENCES FOR PDE6Β EXONS.
Exon Forward primer Reverse primer Annealing
temperature (°C)
1a CTGGTTTTCCTGGAAGGT CTGGCGGTACATGAAGAG 55
1a AGGATATGCAGGAGAGCAT CTCCTCAGCACAGAACTAGC 55
2 TCTGCTGGACTGAGCACT GCAGGTAAAGAGGTGGATG 55
3 GTGCACCTGAGCTTGTGTGT ACCTACCCAGGTGAGCACAA 60
4 CCACAAGCTCAGATGAAACCT ATCAGCACAGACCACACGTC 59
5 AAGGAGAAGGTGAGGCTTCC CTGGTGGAGACCACAGACAG 59
6 GGAACACAGACTGGGAAGAC AGTGAGTCGGCTTCTGTCTC 57
7–8 ACACACACGTGCAGCCTA AGTGGCAAAAACGAATTCAC 57
9 AAACTCCAAATGCAGAGAGG TGCTTCTGTGTGGGGTCT 57
10 AGACCCCACACAGAAGCACT CTGTGACCCCTCAATGGAC 59
11 ACGGTCATTTGTCTCCAGAT AGTCAGGCCCACTAAACATC 57
12 AACTGGGCAAGTTCTTCACT TACTTCCCGTGTGCATTTTA 56
13 GAAGTCCAGGAGACGGTGT AGGGGTTGGGATGACCTA 57
14 TACCAAGGGCAGCACTCA CGCCACCATACACAGCTT 58
15 CAGGAGGTCAAGGCTGTATT CACTGAGTGTCCAGGTCCTT 56
16 CCAAGGACCTGGACACTCA GTGGGAGCAAGTGTGGAGA 59
17 CCTGGCCCTGTACTTCAA CAAGGGCTACAGACCAATG 57
18 GAGGCTGAGGCACAAGAATC ACTGCAGTACCCCCATCCTT 55
19 GGCAACGGACCATTGTTT TGAGATAAGGACCCCACGAC 59
20 TCCATGAGCACATCTGAGTGA TCCGGAAACTGATGTTCCTC 60
21 CGAGGTTTCTCCCTTCACAG TGGCTCTGCTTTTCTCCATT 59
22 TGAGCATAATCAGGGCACAG TTGGGCTTCCTAACCTCTTG 59
               The amplification conditions are described in the Methods.
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1374GeneAmp PCR buffer, 1 mM dNTP mix, 2.5 mM MgCl2, and
0.2  U  of  Taq  DNA  polymerase.  Initial  denaturation  was
performed for 5 min at 95 °C, followed by 10 cycles of 15 s
at 94 °C, 15 s at 55 °C, and 30 s at 72 °C and then 20 cycles
of 15 s at 89 °C, 15 s at 55 °C, and 30 s at 72 °C. The final
extension was performed for 10 min at 72 °C and followed by
a final hold at 4 °C. PCR products from each DNA sample
were pooled and mixed with HD-400 size standards (Applied
Biosystems). The resulting PCR products were separated in
an ABI3100 DNA analyzer, and alleles were assigned using
Genotyper Software version 3.7 (Applied Biosystems).
Linkage  analysis:  Two-point  linkage  analyses  were
performed using the FASTLINK version of MLINK from the
LINKAGE   Program Package, whereas  the maximum two- 
point LOD  scores  were  calculated  with  ILINK  from  the 
LINKAGE Program Package [11,12]. arRP was analyzed as
a  fully  penetrant  trait  with an  affected allele  frequency of
0.001. The marker order and distances between the  markers
were obtained from the Marshfield  database   and the NCBI
chromosome 4 sequence maps. For the initial genome scan,
equal  allele  frequencies  were  assumed,  while  for  fine
mapping, allele frequencies were estimated from 96 unrelated
and  unaffected  individuals  from  the  Punjab  province  of
Pakistan.
Mutation  Screening:  Primer  pairs  of  individual  exons  of
PDE6β  were  designed  using  the  primer3  software.  The
sequences and annealing temperatures are shown in Table 1.
Amplifications were performed in a 25-μl reaction containing
50 ng of genomic DNA, 8 pM of each primer, 250 μM dNTP
mix, 2.5 mM MgCl2, and 0.2 U Taq DNA polymerase in the
standard  1×  PCR  buffer  provided  by  the  manufacturer
(Applied  Biosystems).  PCR  amplification  consisted  of  a
denaturation step at 96 °C for 5 min, followed by 40 cycles,
each consisting of 96 °C for 45 s followed by 57 °C (or specific
annealing temperature of the primer pair) for 45 s and at 72 °C
for 1 min. PCR products were analyzed on a 2% agarose gel,
precipitated, and purified by ethanol precipitation. The PCR
primers for each exon were used for bidirectional sequencing
using Big Dye Terminator Ready reaction mix according to
manufacturer instructions (Applied Biosystems). Sequencing
products  were  resuspended  in  10  μl  formamide  (Applied
Biosystems) and denatured at 95 °C for 5 min. Sequencing
was performed on an ABI PRISM 3100 Automated sequencer
(Applied Biosystems). Sequencing results were assembled
using ABI PRISM sequencing analysis software version 3.7
and analyzed using SeqScape software (Applied Biosystems).
Prediction  Analysis:  Evolutionary  conservation  of  the
mutated amino acid residues in other PDE6β orthologs was
examined using the UCSC genome browser. The degree of
evolutionary  conservation  of  these  amino  acids  and  the
possible impact of an amino acid substitution on the structure
of  PDE6β  was  investigated  with  PolyPhen  and  Sorting
Figure 1. Pedigree drawings of families PKRP161 and PKRP183 with haplotyes of five adjacent chromosomes 4p microsatellite markers and
variations identified in PDE6β. Single base changes: c.1655G>A and c.1160C>T were identified in PKRP161 and PKRP183, respectively
and segregate with the disease phenotype in their respective families. Squares: males; circles: females; filled symbols: affected individuals;
double lines between individuals: consanguineous mating; and a diagonal line through a symbol: a deceased family member. Alleles forming
the risk haplotype are shaded black and alleles not co-segregating with retinitis pigmentosa are shown in white.
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1375Figure 2. Fundus photographs of affected individuals of families PKFP161 and PKRP183. A: OD and OS of affected individual 17 of PKRP161
(age: 28 years). B: OD and OS of affected individual 7 of PKRP183 (age: 55 years). C: OD and OS of unaffected individual 19 of PKRP183
(age: 51 years). Photographs show peripheral fundus demonstrating several features associated with RP including a waxy pallor of the optic
disc, attenuated arterioles and peripheral bone spicules. Visual acuity were recorded as 6/24, 6/24 (OD, OS) and 6/18, 6/18 (OD, OS) for
individual 17 of PKRP161 and individual 7 of PKRP183, respectively. OD: Oculus Dexter (right eye); and OS: Oculus Sinister (left eye).
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1376Intolerant From Tolerant (SIFT) tools available online [13,
14].
RESULTS
The families described in this study, PKRP161 and PKRP183,
are  from  the  Punjab  province  of  Pakistan  (Figure  1).  All
affected individuals underwent a thorough ophthalmologic
examination that concluded that all affected individuals in the
two families fulfill the diagnostic criteria of RP. Affected
patients  presented  symptoms  of  night  blindness  in  early
childhood. Fundus examination of affected patients illustrated
cardinal features of RP, namely arteriolar constriction, waxy
pallor optic disc, and pigmentation on the peripheral as well
as central retina (Figure 2). ERG recordings showed absence
of both rod and cone responses; scotopic and photopic ERG
responses were highly reduced or absent (Figure 3).
Exclusion  analyses  with  closely  spaced  STR  markers
spanning the known/reported loci for arRP were completed.
The  results  of  these  analyses  strongly  suggested  that  the
pathogenic mutation in PKRP161 and PKRP183 resides in a
region on chromosome 4p. For PKRP161 maximum two-
point LOD scores of 3.77, 3.75, 3.63, and 3.66 were obtained
with  D4S3360,  D4S2936,  D4S3038,  and  D4S1614,
respectively at θ=0 (Table 2). Similarly for PKRP183, two-
point LOD scores of 3.08, 3.12, and 3.16 were obtained for
markers D4S2936, D4S3038, and D4S1614, respectively at
θ=0 (Table 2).
Figure 3. Electroretinography recordings of affected individuals of families PKFP161 and PKRP183. A: OD combined rod and cone response,
and OD isolated cone response. B: OS combined rod and cone response; and OS isolated cone response of affected individual 17 of PKRP161.
C: OD: combined rod and cone response, and isolated cone response. D: OS: combined rod and cone response, and isolated cone response of
affected individual 7 PKRP183. E: OD: combined rod and cone response and isolated cone response. F: OS: combined rod and cone response
and, isolated cone response of unaffected individual 18 of PKRP161. Affected individuals show loss of both rod and cone responses consistent
with the diagnosis of Retinitis pigmentosa, whereas the unaffected has normal rod and cone responses. OD: Oculus Dexter (right eye); and
OS: Oculus Sinister (left eye).
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1377Haplotype analyses confirmed the linkage results, and
visual inspection of these haplotypes localized the disease to
chromosome 4p. We did not find any proximal recombination
events  in  any  affected  individuals,  whereas  the  distal
boundary  was  defined  by  a  recombination  in  affected
individuals  17  and  22  of  family  PKRP161  and  affected
individual 12 of family PKRP183 at D4S3023. This places the
disease interval in an 8.24 cM (4.3 Mb) region on chromosome
4pter-p16.2.  Alleles  for  markers  D4S3360,  D4S2936,
D4S3038,  and  D4S1614  are  homozygous  in  affected
individuals of the two families.
The linked region on chromosome 4pter-p16.2 harbors
PDE6β, a gene that has previously been associated with the
causality of arRP. We sequenced all coding exons, exon–
intron boundaries, and the 5′ and 3′ untranslated regions of
PDE6β. In PKRP161 we identified a missense mutation c.
1655G>A (Figure 4), which results in an arginine residue
substituted by a glutamine residue at position 552: p.R552Q.
Similarly, we identified the novel missense variation c.1160
C>T in PKRP183 (Figure 4), which leads to a proline residue
substituted by leucine at position 387: p.P387L. None of these
two variations were present in 192 ethnically matched control
chromosomes.
As shown in Figure 5, both amino acid residues P387 and
R552 are highly conserved among other PDE6β orthologs;
therefore we next examined the possible impact of these two
variations on PDE6β with SIFT and PolyPhen algorithms.
SIFT predictions suggested that both p.P387L and p.R552Q
TABLE 2. TWO-POINT LOD AT DIFFERENT RECOMBINATION FRACTIONS OF FAMILIES.
Marker cM Mb 0 0.01 0.05 0.1 0.2 0.3 Zmax θmax
A:
D4S3360 0 0.11 3.77 3.69 3.39 3.01 2.17 1.43 3.77 0
D4S2936 1.48 0.69 3.75 3.66 3.35 3.04 2.12 1.38 3.75 0
D4S3038 1.48 1.09 3.63 3.56 3.25 2.86 2.04 1.21 3.63 0
D4S1614 4.74 2.64 3.66 3.58 3.27 2.89 2.07 1.27 3.66 0
D4S3023 8.24 4.3 - ∞ −1.57 −0.84 −0.31 −0.14 0.14 0.14 0.3
B:
D4S3360 0 0.11 0.98 1.96 0.88 0.76 0.5 0.26 1.96 0.01
D4S2936 1.48 0.69 3.08 3.01 2.8 2.38 1.55 0.85 3.08 0
D4S3038 1.48 1.09 3.12 3.05 2.84 2.41 1.59 0.91 3.12 0
D4S1614 4.74 2.64 3.16 3.1 2.77 2.36 1.54 0.78 3.16 0
D4S3023 8.24 4.3 - ∞ −1.45 −0.75 −0.28 −0.12 0.1 0.1 0.3
            A: PKRP161 and B: PKRP183 with alleles of chromosome 4p STR markers.
Figure 4. The sequence chromatograms
of  families  PKRP161  and  PKRP183.
A:  Unaffected  individual  20  of
PKRP161  heterozygous.  B:  Affected
individual 17 homozygous for a single
base change: c.1655G>A, leading to an
Arginine  to  Glutamine  substitution:
p.R552Q. C: Unaffected individual 11
of family PKRP183 heterozygous. D:
Affected individual 7 homozygous for a
base  change:  c.1160  C>T,  leading  to
Proline  to  Leucine  substitution:
p.P387L.
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1378substitutions  will  not  be  tolerated  by  the  native  three
dimensional  structure  of  PDE6β.  The  affected  protein
function score for p.P387L and p.R552Q were 0.01 and 0.02,
respectively (scores <0.05 are predicted to be damaging).
Likewise, position-specific score differences obtained from
Polyphen  suggested  that  both  p.P387L  and  p.R552Q
substitutions could potentially have deleterious effect on the
PDE6β structure, with a position- specific independent count
scores of 3.09 and 2.24, respectively (scores >1 are predicted
to be damaging).
DISCUSSION
Here, we report two consanguineous Pakistani families with
multiple  family  members  affected  with  arRP.  Exclusion
linkage analyses localized the critical interval to chromosome
4pter-p16.2 with significant LOD scores, and bidirectional
sequencing identified two missense mutations, p.P387L and
p.R552Q, that segregated with the disease phenotype in their
respective families. These mutations were absent in ethnically
matched control chromosomes and involved amino acids that
are highly conserved in other PDE6β orthologs. These results
strongly suggest that mutations in PDE6β are responsible for
the  disease  phenotype  in  the  consanguineous  Pakistani
families.
In this study we interrogated 125 families with closely
spaced  STR  markers  spanning  the  chromosome  4p  locus
harboring PDE6β but we only identified two families linked
to the chromosome 4p locus, which suggests that mutations
in PDE6β do not contribute significantly to the genetic load
of arRP in the Punjab province of Pakistan.
Previously, Mou and colleagues [15,16] showed that the
γ subunit of PDE6 interacts with at least two distinct sites on
the catalytic subunit, and these interactions are regulated by
cGMP  binding  to  the  regulatory  cGMP-binding  PDEs,
Anabaena  adenylyl  cyclases,  and  Escherichia  coli  FhlA
(GAF)  domains.  Of  the  two  mutations  identified  in  here,
p.R552Q has previously been reported to be associated with
arRP and resides in the catalytic domain of PDE6β, where it
is presumed to perturb catalytic activity of the enzyme [17].
On  the  other  hand  p.P387L  is  believed  to  reside  in  the
regulatory GAF domain, but the mechanism of the causality
remains unknown.
Identification  of  pathogenic  mutations  reaffirms  the
allelic heterogeneity of PDE6β in the pathogenesis of RP, and
future studies investigating the mechanism of the causality
will help us better understand the molecular mechanism of the
disease phenotype, which will lead to better treatments and
novel therapeutics.
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